# Comparing Daily vs Intermittent Regimen of ATT in HIV With Pulmonary Tuberculosis

> **NCT00933790** · PHASE3 · COMPLETED · sponsor: **Tuberculosis Research Centre, India** · enrollment: 331 (actual)

## Conditions studied

- HIV Infection
- Pulmonary TB

## Interventions

- **DRUG:** ATT (Ethambutol, Pyrazinamide, INH, Rifampicin)

## Key facts

- **NCT ID:** NCT00933790
- **Lead sponsor:** Tuberculosis Research Centre, India
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09-14
- **Primary completion:** 2016-12-31
- **Final completion:** 2018-06-30
- **Target enrollment:** 331 (ACTUAL)
- **Last updated:** 2019-04-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00933790

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00933790, "Comparing Daily vs Intermittent Regimen of ATT in HIV With Pulmonary Tuberculosis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00933790. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*